Cargando…
Investing in health R&D: where we are, what limits us, and how to make progress in Africa
Global research and development (R&D) pipelines for diseases that disproportionately affect African countries appear to be inadequate, with governments struggling to prioritise investment in R&D. This article provides insights into the sources of investment in health science research, availa...
Autores principales: | Simpkin, Victoria, Namubiru-Mwaura, Evelyn, Clarke, Lorcan, Mossialos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407556/ https://www.ncbi.nlm.nih.gov/pubmed/30899571 http://dx.doi.org/10.1136/bmjgh-2018-001047 |
Ejemplares similares
-
International collaboration and covid-19: what are we doing and where are we going?
por: Bump, Jesse B, et al.
Publicado: (2021) -
Health sector governance: should we be investing more?
por: Fryatt, Robert, et al.
Publicado: (2017) -
What we have learnt (so far) about deliberative dialogue for evidence-based policymaking in West Africa
por: Ridde, Valéry, et al.
Publicado: (2017) -
The limits of shared decision making
por: Elwyn, Glyn, et al.
Publicado: (2023) -
Investing in trust and community resilience: lessons from the early months of the first digital pandemic
por: Abdalla, Salma M, et al.
Publicado: (2021)